After a multicenter randomized sham-controlled trial of Deep TMSTM therapy for obsessive-compulsive disorder (OCD) demonstrated a 38% response rate that is sustained for at least four weeks [1] the FDA granted a de novo clearance for the H7 Coil. In realworld clinical practice settings 52.4% of p…